TWIST1 and non-small cell lung carcinoma: Harmine, an alkaloid compound with anti-tumor activity in various oncogene-driven NSCLC types, has been shown efficacy in promoting TWIST1 protein degradation, suggesting a therapeutic strategy for treating oncogene-driven NSCLC [129].